192 Publications (Page 4 of 8)
2013
Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancerEllis, Leigh⋅Ku, ShengYu⋅Ramakrishnan, Swathi⋅Lasorsa, Elena⋅Azabdaftari, Gizzou⋅Godoy, Alejandro and Pili, RobertoOncotarget, vol. 4, (no. 12), pp. 2236, 2013-12-31.
| Journal Article
Dietary protein restriction inhibits tumor growth in human xenograft models.Fontana, Luigi⋅Adelaiye, Remi M⋅Rastelli, Antonella L⋅Miles, Kiersten M⋅Ciamporcero, Eric⋅Longo, Valter D⋅Nguyen, Holly⋅Vessella, Robert and Pili, RobertoOncotarget, vol. 4, (no. 12), pp. 2451-61, 2013/Dec.
| Journal Article
Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancerFontana, Luigi⋅Adelaiye, Remi M⋅Rastelli, Antonella L⋅Miles, Kiersten Marie⋅Ciamporcero, Eric⋅Longo, Valter D⋅Nguyen, Holly⋅Vessella, Robert and Pili, RobertoOncotarget, vol. 4, (no. 12), pp. 2461, 2013-12-31.
| Journal Article
High-dose interleukin-2 therapy for metastatic renal cell carcinoma: A contemporary experienceAboumohamed, Ahmed A⋅Yarlagadda, Naveen⋅Creighton, Terrance⋅Mehedint, Diana⋅Attwood, Kristopher⋅Kauffman, Eric⋅George, Saby⋅Khushalani, Nikhil I⋅Pili, Roberto and Schwaab, ThomasJournal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. e15604, 2013-05-20.
| Journal Article
Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.Ramakrishnan, Swathi and Pili, RobertoCancer journal (Sudbury, Mass.), vol. 19, (no. 4), pp. 333-340.
| Journal Article
Histone modifications: implications in renal cell carcinomaRamakrishnan, Swathi⋅Ramakrishnan, Swathi⋅Ellis, Leigh⋅Ellis, Leigh⋅Pili, Roberto and Pili, RobertoEpigenomics, vol. 5, (no. 4), pp. 462, 2013-August-01.
| Journal Article
Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.Armstrong, Andrews J⋅Häggman, M⋅Stadler, W M⋅Gingrich, J R⋅Assikis, V⋅Polikoff, J⋅Damber, J E⋅Belkoff, L⋅Nordle, Ö⋅Forsberg, G⋅Carducci, M A and Pili, RClinical cancer research : an official journal of the American Association for Cancer Research, vol. 19, (no. 24), pp. 6891-901, 2013/Dec/15.
| Journal Article
Major response to cyclophosphamide and prednisone in recurrent castration-resistant prostate cancer.Batty, Nicolas⋅Yarlagadda, Naveen and Pili, RobertoJournal of the National Comprehensive Cancer Network : JNCCN, vol. 11, (no. 8), pp. 911-915, August 2013.
| Journal Article
Tasquinimod: A Novel Angiogenesis Inhibitor–Development in Prostate CancerGeorge, Saby⋅George, Saby⋅Pili, Roberto and Pili, RobertoCurrent Oncology Reports, vol. 15, (no. 2), pp. 68, 20130400.
| Journal Article
Understanding Avoidance, Refusal, and Abandonment of Chemotherapy Before and After Cystectomy for Bladder CancerRehman, Shabnam⋅Rehman, Shabnam⋅Crane, Alice⋅Crane, Alice⋅Din, Rakeeba⋅Din, Rakeeba⋅Raza, Syed J⋅Raza, Syed⋅Shi, Yi⋅Shi, Yi⋅Wilding, Gregory A⋅Wilding, Gregory⋅Levine, Ellis⋅Levine, Ellis G⋅George, Saby⋅George, Saby⋅Pili, Roberto⋅Pili, Roberto⋅Trump, Donald L⋅Trump, Donald⋅Guru, Khurshid and Guru, Khurshid AUrology, vol. 82, (no. 6), pp. 1375, 2013.
| Journal Article
Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse ModelChatterjee, Subroto⋅Chatterjee, Subroto⋅Alsaeedi, Nezar⋅Alsaeedi, Nezar⋅Hou, Jennifer⋅Hou, Jennifer⋅Bandaru, Veera Venkata Ratnam⋅Wu, Lan⋅Wu, Lan⋅Halushka, Marc K⋅Halushka, Marc K⋅Pili, Roberto⋅Pili, Roberto⋅Ndikuyeze, Georges⋅Ndikuyeze, Georges⋅Haughey, Norman J and Haughey, Norman JPloS one, vol. 8, (no. 5), pp. e63726, 2013-00-00.
| Journal Article
2012
A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malateBruce, Justine Y⋅Bruce, Justine⋅Bruce, Justine⋅Eickhoff, Jens⋅Eickhoff, Jens⋅Eickhoff, Jens⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Logan, Theodore⋅Logan, Theodore⋅Logan, Theodore⋅Carducci, Michael⋅Carducci, Michael⋅Carducci, Michael⋅Arnott, Jamie⋅Arnott, Jamie⋅Arnott, Jamie⋅Treston, Anthony⋅Treston, Anthony⋅Treston, Anthony⋅Wilding, George⋅Wilding, George⋅Wilding, George⋅Liu, Glenn⋅Liu, Glenn and Liu, GlennInvestigational New Drugs, vol. 30, (no. 2), pp. 802, 20120400.
| Journal Article
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinomaKeizman, Daniel⋅Keizman, Daniel⋅Ish-Shalom, Maya⋅Ish-Shalom, Maya⋅Pili, Roberto⋅Pili, Roberto⋅Hammers, Hans⋅Hammers, Hans⋅Eisenberger, Mario A⋅Eisenberger, Mario⋅Sinibaldi, Victoria⋅Sinibaldi, Victoria⋅Boursi, Ben⋅Boursi, Ben⋅Maimon, Natalie⋅Maimon, Natalie⋅Gottfried, Maya⋅Gottfried, Maya⋅Hayat, Henry⋅Hayat, Henry⋅Peer, Avivit⋅Peer, Avivit⋅Kovel, Svetlana⋅Kovel, Svetlana⋅Sella, Avishay⋅Sella, Avishay⋅Berger, Raanan⋅Berger, Raanan⋅Carducci, Michael and Carducci, Michael AEuropean Journal of Cancer, vol. 48, (no. 7), pp. 1037, 2012.
| Journal Article
Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapyShen, Li⋅Shen, Li⋅Pili, Roberto and Pili, RobertoOncoImmunology, vol. 1, (no. 6), pp. 950, 9/1/2012.
| Journal Article
Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer ModelsShen, Li⋅Shen, Li⋅Shen, Li⋅Ciesielski, Michael⋅Ciesielski, Michael⋅Ciesielski, Michael J⋅Ramakrishnan, Swathi⋅Ramakrishnan, Swathi⋅Ramakrishnan, Swathi⋅Miles, Kiersten M⋅Miles, Kiersten M⋅Miles, Kiersten M⋅Ellis, Leigh⋅Ellis, Leigh⋅Ellis, Leigh⋅Sotomayor, Paula⋅Sotomayor, Paula⋅Sotomayor, Paula⋅Shrikant, Protul⋅Shrikant, Protul⋅Shrikant, Protul⋅Fenstermaker, Robert⋅Fenstermaker, Robert⋅Fenstermaker, Robert A⋅Pili, Roberto⋅Pili, Roberto and Pili, RobertoPloS one, vol. 7, (no. 1), pp. e30815, 2012-00-00.
| Journal Article
Contrasting effects of sunitinib within in vivo models of metastasis.Welti, Jonathan C⋅Powles, Thomas⋅Foo, Shane⋅Gourlaouen, Morgane⋅Preece, Natasha⋅Foster, Julie⋅Frentzas, Sophia⋅Bird, Demelza⋅Sharpe, Kevin⋅van Weverwijk, Antoinette⋅Robertson, David⋅Soffe, Julie⋅Erler, Janine T⋅Pili, Roberto⋅Springer, Caroline J⋅Mather, Stephen J and Reynolds, Andrew RAngiogenesis, vol. 15, (no. 4), pp. 623-41, 2012/Dec.
| Journal Article
Development of a castrate resistant transplant tumor model of prostate cancerEllis, Leigh⋅Ellis, Leigh⋅Lehet, Kristin⋅Lehet, Kristin⋅Ramakrishnan, Swathi⋅Ramakrishnan, Swathi⋅Adelaiye, Remi⋅Adelaiye, Remi⋅Pili, Roberto and Pili, RobertoThe Prostate, vol. 72, (no. 6), pp. 591, 1 May 2012.
| Journal Article
Mind the Gap: Potential for Rebounds during Antiangiogenic Treatment BreaksEbos, John M L⋅Ebos, John M⋅Pili, Roberto and Pili, RobertoClinical cancer research : an official journal of the American Association for Cancer Research, vol. 18, (no. 14), pp. 3721, 2012-Jul-15.
| Journal Article
Modulation of Chemotherapeutic Efficacy by Vascular Disrupting Agents: Optimizing the Sequence and ScheduleWang, Eunice S⋅Wang, Eunice S⋅Pili, Roberto⋅Pili, Roberto⋅Seshadri, Mukund and Seshadri, MukundJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, (no. 7), pp. 761, 2012-Mar-01.
| Journal Article
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cellsMinelli, Rosalba⋅Minelli, Rosalba⋅Cavalli, Roberta⋅Cavalli, Roberta⋅Ellis, Leigh⋅Ellis, Leigh⋅Pettazzoni, Piergiorgio⋅Pettazzoni, Piergiorgio⋅Trotta, Francesco⋅Trotta, Francesco⋅Ciamporcero, Eric⋅Ciamporcero, Eric⋅Barrera, Giuseppina⋅Barrera, Giuseppina⋅Fantozzi, Roberto⋅Fantozzi, Roberto⋅Dianzani, Chiara⋅Dianzani, Chiara⋅Pili, Roberto and Pili, RobertoEuropean Journal of Pharmaceutical Sciences, vol. 47, (no. 4), pp. 694, 2012-11-20.
| Journal Article
Pretreatment Neutrophil‐to‐Lymphocyte Ratio in Metastatic Castration‐Resistant Prostate Cancer Patients Treated With Ketoconazole: Association with Outcome and Predictive NomogramKeizman, Daniel⋅Keizman, Daniel⋅Gottfried, Maya⋅Gottfried, Maya⋅Ish‐Shalom, Maya⋅Ish-Shalom, Maya⋅Maimon, Natalie⋅Maimon, Natalie⋅Peer, Avivit⋅Peer, Avivit⋅Neumann, Avivit⋅Neumann, Avivit⋅Rosenbaum, Eli⋅Rosenbaum, Eli⋅Kovel, Svetlana⋅Kovel, Svetlana⋅Pili, Roberto⋅Pili, Roberto⋅Sinibaldi, Victoria⋅Sinibaldi, Victoria⋅Carducci, Michael A⋅Carducci, Michael A⋅Hammers, Hans⋅Hammers, Hans⋅Eisenberger, Mario A⋅Eisenberger, Mario A⋅Sella, Avishay and Sella, AvishayThe Oncologist, vol. 17, (no. 12), pp. 1514, December 2012.
| Journal Article
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibitionChintala, Sreenivasulu⋅Chintala, Sreenivasulu⋅Najrana, Tanbir⋅Najrana, Tanbir⋅Toth, Karoly⋅Toth, Karoly⋅Cao, Shousong⋅Cao, Shousong⋅Durrani, Farukh A⋅Durrani, Farukh A⋅Pili, Roberto⋅Pili, Roberto⋅Rustum, Youcef M and Rustum, Youcef MBMC cancer, vol. 12, (no. 1), pp. 293, 2012-Jul-17.
| Journal Article
Testicular CancerGrivas, P⋅Motzer, Robert J⋅Motzer, RJ⋅Motzer, Robert J⋅Agarwal, Neeraj⋅Agarwal, N⋅Agarwal, Neeraj⋅Smith, Dc⋅Beard, C⋅Beard, Clair⋅Beard, Clair⋅Bhayani, Sam⋅Bhayani, S⋅Bhayani, Sam⋅Bolger, Graeme B⋅Bolger, GB⋅Bolger, Graeme B⋅Buyyounouski, Mark K⋅Buyyounouski, MK⋅Buyyounouski, Mark K⋅Carducci, Michael A⋅Carducci, Michael A⋅Carducci, MA⋅Chang, SS⋅Chang, Sam S⋅Chang, Sam S⋅Choueiri, Toni K⋅Choueiri, Toni K⋅Choueiri, TK⋅Gupta, S⋅Gupta, Shilpa⋅Gupta, Shilpa⋅Hancock, SL⋅Hancock, Steven L⋅Hancock, Steven L⋅Hudes, GR⋅Hudes, Gary R⋅Hudes, Gary R⋅Jonasch, E⋅Jonasch, Eric⋅Jonasch, Eric⋅Kuzel, TM⋅Kuzel, Timothy M⋅Kuzel, Timothy M⋅Lau, Clayton⋅Lau, Clayton⋅Lau, C⋅Levine, EG⋅Levine, Ellis G⋅Levine, Ellis G⋅Lin, DW⋅Lin, Daniel W⋅Lin, Daniel W⋅Margolin, Kim A⋅Margolin, KA⋅Margolin, Kim A⋅Michaelson, M Dror⋅Michaelson, MD⋅Michaelson, M Dror⋅Olencki, Thomas⋅Olencki, T⋅Olencki, Thomas⋅Pili, Roberto⋅Pili, Roberto⋅Pili, R⋅Ratliff, TW⋅Ratliff, Thomas W⋅Ratliff, Thomas W⋅Redman, Bruce G⋅Redman, Bruce G⋅Redman, BG⋅Robertson, Cary N⋅Robertson, CN⋅Robertson, Cary N⋅Ryan, CJ⋅Ryan, Charles J⋅Ryan, Charles J⋅Sheinfeld, Joel⋅Sheinfeld, J⋅Sheinfeld, Joel⋅Wang, Jue⋅Wang, J⋅Wang, Jue⋅Wilder, Richard B⋅Wilder, RB and Wilder, Richard BJournal of the National Comprehensive Cancer Network : JNCCN, vol. 10, (no. 4), pp. 535, 2012-Apr.
| Journal Article
Vascular Disruption in Combination with mTOR Inhibition in Renal Cell CarcinomaEllis, Leigh⋅Ellis, Leigh⋅Shah, Preeti⋅Shah, Preeti⋅Hammers, Hans⋅Hammers, Hans⋅Lehet, Kristin⋅Lehet, Kristin⋅Sotomayor, Paula⋅Sotomayor, Paula⋅Azabdaftari, Gissou⋅Azabdaftari, Gissou⋅Seshadri, Mukund⋅Seshadri, Mukund⋅Pili, Roberto and Pili, RobertoMolecular cancer therapeutics, vol. 11, (no. 2), pp. 392, 2012-Feb.
| Journal Article
2011
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examinationKeizman, Daniel⋅Keizman, Daniel⋅Huang, Peng⋅Huang, Peng⋅Eisenberger, Mario A⋅Eisenberger, Mario⋅Pili, Roberto⋅Pili, Roberto⋅Kim, Jenny J⋅Kim, Jenny⋅Antonarakis, Emmanuel S⋅Antonarakis, Emmanuel⋅Hammers, Hans⋅Hammers, Hans⋅Carducci, Michael A and Carducci, MichaelEuropean Journal of Cancer, vol. 47, (no. 13), pp. 1961, 2011.
| Journal Article